questionText: To ask the Secretary of State for Health and Social Care, what data the Department holds on (a) the number and proportion of dopamine agonist-treated patients who report binge eating or marked weight gain, (b) weight and metabolic monitoring practices when dopamine agonists are started or doses increased, (c) the incidence of new-onset diabetes or serious obesity-related complications in that group and (d) how those findings affect prescribing or dose decisions.
heading: Drugs: Side Effects